PTCE Pharmacy Connect | Pharmacy Times
Pharmacy Times Continuing Education Free Continuing Education By Pharmacists For Pharmacists https://www.pharmacytimes.org/topic?t=Podcast
Listen on:
Episodes
Thursday Jun 30, 2022
Thursday Jun 30, 2022
Educational Objectives
· Understand the impact of Janus kinase inhibitors for the management of atopic dermatitis (AD)
· Examine key safety and efficacy data on new and emerging Janus kinase inhibitors utilized for the treatment of AD and select appropriate treatments
Identify the role of the pharmacist in individualizing treatment for patients with AD through patient counseling and education
Faculty:
Svetlana Gerzenshtein, PharmD, BCPS, CSP
Clinical Pharmacist Specialist
Specialty Pharmacy Department
University of Chicago Medical Center
Chicago, Illinois
Content Development
Sarah Lant, PharmD
Clinical Pharmacist Specialist
UChicago Medicine
Chicago, Illinois
Svetlana Gerzenshtein, PharmD, BCPS, CSP, has no financial relationships with commercial interests to disclose.
Sarah Lant, PharmD, has the following relevant financial relationship with a commercial interest to disclose:
Other (faculty speaker training): Lily
Learn more about your ad choices. Visit megaphone.fm/adchoices
Thursday Jun 30, 2022
Thursday Jun 30, 2022
Educational Objectives
· Recognize the role of biomarker expression in the selection of most appropriate treatment options for patients with endometrial cancer
· Review strategies for identification and management of drug-related toxicities in patients receiving therapy with immune checkpoint inhibitors, targeted agents, or combination therapy
Faculty:
Sarah Hayward, PharmD, BCOP
Clinical Pharmacy Specialist, Gynecologic Oncology
Stephenson Cancer Center at OU Health
University of Oklahoma Health Science Center
Oklahoma City, Oklahoma
Sarah Hayward, PharmD, BCOP, has the following relevant financial relationships with commercial interests to disclose:
Consultant (advisory board): GSK, Seagen/Genmab
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hour (0.05 CEU) under the ACPE universal activity number 0290-0000-22-322-H01-P. The activity is available for CE credit through June 30, 2023.
This educational activity is supported by an educational grant from GlaxoSmithKline
Learn more about your ad choices. Visit megaphone.fm/adchoices
Thursday Jun 30, 2022
Thursday Jun 30, 2022
Introduction of faculty and disclosures:
Dr. Katherine Tobon is a clinical pharmacy specialist in malignant hematology with Moffitt Cancer Center in Tampa, Florida.
Dr. Tobon has no relevant financial relationships with commercial interests to disclose.
Accreditation and support statement:
PTCE is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours of knowledge-based credit.
This activity is supported by an educational grant from Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., Administered by Janssen Scientific Affairs, LLC and BeiGene, Ltd.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Thursday Jun 30, 2022
Thursday Jun 30, 2022
This podcast will specifically focus on clinical safety and efficacy data supporting the use of new and emerging JAK inhibitors in the management of AD. Practical counseling points for pharmacists to provide individualized care and proper selection of therapy to patients with AD who are initiating therapy with JAK inhibitors will also be discussed. Faculty experts will review audience questions and identify best practices in the management of AD.
o The Role of JAK Inhibitors in the Management of Atopic Dermatitis: Latest Advances and Best Practices for the Pharmacist
o Introduction of faculty, affiliations, and disclosures
We would like to thank Sarah Lant, PharmD for her contribution in developing the content for this podcast.
Lana Gerzenshtein, PharmD and Sarah Lant have no relevant financial relationships with commercial interests to disclose.
o Accreditation and support statement
PTCE is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours of knowledge-based credit.
This activity is supported by educational grants from Incyte.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Thursday Jun 30, 2022
Thursday Jun 30, 2022
Introduction of faculty and disclosures:
Dr. Katherine Tobon is a clinical pharmacy specialist in malignant hematology with Moffitt Cancer Center in Tampa, Florida.
Dr. Tobon has no relevant financial relationships with commercial interests to disclose.
Accreditation and support statement:
PTCE is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours of knowledge-based credit.
This activity is supported by an educational grant from Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., Administered by Janssen Scientific Affairs, LLC and BeiGene, Ltd.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Thursday Apr 28, 2022
Thursday Apr 28, 2022
Lisa Dumkow, PharmD, BCIDP, Antimicrobial Stewardship Clinical Pharmacist, PGY-2 Infectious Diseases Pharmacy Residency Program Director, Mercy Health Saint Mary’s, Grand Rapids, MI
Lacy Worden, PharmD, PGY-2 Infectious Diseases Pharmacy resident, Mercy Health Saint Mary’s, Grand Rapids MI [LP1]
Dr. Dumkow & Dr. Worden have no relevant financial relationships with commercial interests to disclose
PTCE is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hour of knowledge-based credit.
This activity is supported by educational grants from GlaxoSmithKline.
The educational objectives for this activity are:
o Examine important milestones and recent updates in the treatment and management of COVID-19
o Interpret safety and efficacy data for recently approved, authorized, or investigational agents for the treatment of COVID-19
o Illustrate how pharmacists can assist with educating patients and other health care providers regarding the latest updates to the treatment of COVID-19
Summary statement of topic being discussed: This is a conversational interview which will focus on emerging therapies for the management of COVID-19 in the outpatient setting. A discussion around current and investigational therapies will be covered. Key takeaways and practical points will be the focus.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Thursday Mar 31, 2022
Thursday Mar 31, 2022
Educational Objectives
Examine challenges in current treatment options for seizure clusters, including efficacy and safety, and differentiating routes of administration
Highlight considerations in treatment of seizure clusters, including addressing barriers to treatment and providing patient counseling to improve outcomes
Faculty:
Gretchen M. Brophy, PharmD, BCPS, FCCP, FCCM, FCCM, FNCS, MCCM
Professor
Departments of Pharmacotherapy & Outcomes Science and Neurosurgery
Virginia Commonwealth University, Medical College of Virginia
Richmond, Virginia
Neurocritical Care Clinical Pharmacist
Virginia Commonwealth University Health
Richmond, Virginia
Gretchen M. Brophy, PharmD, BCPS, FCCP, FCCM, FCCM, FNCS, MCCM, has the following relevant financial relationships with commercial interests to disclose:
Grant/Research Support: Department of Defense
Consultant: UCB, Chiesi, Marinus, Alexion, Ceribell
Speakers Bureau: UCB, Chiesi
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hour (0.05 CEU) under the ACPE universal activity number 0290-0000-22-129-H01-P. The activity is available for CE credit through March 31, 2023.
This activity is supported by an educational grant from Neurelis Inc.
Gretchen M. Brophy, PharmD, BCPS, FCCP, FCCM, FNCS, MCCM is Professor of Pharmacotherapy & Outcomes Sciences and Neurosurgery at Virginia Commonwealth University (VCU) School of Pharmacy, Medical College of Virginia Campus. She is a Past President of the Neurocritical Care Society. Dr. Brophy’s research interests include neuropharmacotherapy, traumatic brain injury, biomarkers, hemostasis, stroke, and status epilepticus.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Wednesday Mar 30, 2022
Wednesday Mar 30, 2022
Educational Objectives
Describe the impact of ADHD and new non-stimulant class of ADHD treatments
Highlight the role of the pharmacist in patient counseling, monitoring and medication management in ADHD
Faculty:
Sandy Mullen, PharmD, BCPP
Clinical Pharmacy Specialist - Child and Adolescent Psychiatry
Department of Pharmacy
Virginia Commonwealth University (VCU) Health
Richmond, VA
Sandy Mullen, PharmD, BCPP, has no financial relationships with commercial interests to disclose.
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.75 contact hours (0.075 CEU) under the ACPE universal activity number 0290-0000-22-127-H01-P. The activity is available for CE credit through March 30, 2023.
This activity is supported by an educational grant from Supernus.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Monday Feb 28, 2022
Monday Feb 28, 2022
Educational Objectives
• Review the clinical and economic burdens associated with transthyretin amyloidosis (ATTR)
• Recall key characteristics supporting the use of current and emerging therapies for the treatment of ATTR including mechanisms of action, clinical data, dosing, administration, and potential adverse effects
Faculty:
Svetlana Goldman, PharmD, BCACP, CDCES
Clinical Pharmacist
UC Davis Health
Sacramento, California
Yvette Hellier, PharmD, BCACP
Clinical Pharmacist
UC Davis Health
Sacramento, California
The following contributors have no relevant financial relationships with commercial interests to disclose:
Faculty
Svetlana Goldman, PharmD, BCACP, CDCES, and Yvette Hellier, PharmD, BCACP
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.75 contact hour (0.075 CEU) under the ACPE universal activity number 0290-0000-22-045-H01-P. The activity is available for CE credit through February 28, 2023.
This activity is supported by an educational grant from Alnylam Pharmaceuticals.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Thursday Feb 24, 2022
Thursday Feb 24, 2022
Educational Objectives
Describe the impact of COVID-19 on surgical pain management
Review current postoperative pain management guidelines and emerging non-opioid treatment approaches for pain management, including safety and efficacy data on newer treatments, and key considerations for pharmacists
Faculty:
Jawad N. Saleh, PharmD, BS, BCPS, BCCCP
Clinical Manager of Pharmacy Services
Pharmacy Department
The Hospital for Special Surgery
New York, New York
Faculty, has the following financial relationships with commercial interests to disclose:
Jawad N. Saleh, PharmD, BS, BCPS, BCCCP, has the following relevant financial relationships with commercial interests to disclose:
Consultant: Heron Therapeutics, Baudax Bio
Speakers Bureau: Heron Therapeutics, Baudax Bio
Scientific Advisory Boards: Heron Therapeutics, Baudax Bio
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.75 contact hour (0.075 CEU) under the ACPE universal activity number 0290-0000-22-046-H08-P. The activity is available for CE credit through February 24, 2023.
This activity is supported by an educational grant from Heron.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Your Title
This is the description area. You can write an introduction or add anything you want to tell your audience. This can help potential listeners better understand and become interested in your podcast. Think about what will motivate them to hit the play button. What is your podcast about? What makes it unique? This is your chance to introduce your podcast and grab their attention.